Filed: May 11, 2018
Latest Update: May 11, 2018
Summary: ORDER GRANTING DEFENDANTS' UNOPPOSED MOTION FOR EXTENSION OF TIME TO MOVE, ANSWER, OR OTHERWISE RESPOND TO PLAINTIFFS' COMPLAINT DAVID A. SANDERS , Magistrate Judge . Based upon Defendants' Unopposed Motion for Extension of Time to Move, Answer, or Otherwise Respond to Plaintiffs' Complaint, IT IS HEREBY ORDERED that Defendants McKesson Corporation; Cardinal Health, Inc.; AmerisourceBergen Corporation; CVS Health Corporation; Walgreens Boots Alliance, Inc.; Wal-Mart Stores, Inc.; Purdue
Summary: ORDER GRANTING DEFENDANTS' UNOPPOSED MOTION FOR EXTENSION OF TIME TO MOVE, ANSWER, OR OTHERWISE RESPOND TO PLAINTIFFS' COMPLAINT DAVID A. SANDERS , Magistrate Judge . Based upon Defendants' Unopposed Motion for Extension of Time to Move, Answer, or Otherwise Respond to Plaintiffs' Complaint, IT IS HEREBY ORDERED that Defendants McKesson Corporation; Cardinal Health, Inc.; AmerisourceBergen Corporation; CVS Health Corporation; Walgreens Boots Alliance, Inc.; Wal-Mart Stores, Inc.; Purdue P..
More
ORDER GRANTING DEFENDANTS' UNOPPOSED MOTION FOR EXTENSION OF TIME TO MOVE, ANSWER, OR OTHERWISE RESPOND TO PLAINTIFFS' COMPLAINT
DAVID A. SANDERS, Magistrate Judge.
Based upon Defendants' Unopposed Motion for Extension of Time to Move, Answer, or Otherwise Respond to Plaintiffs' Complaint,
IT IS HEREBY ORDERED that Defendants McKesson Corporation; Cardinal Health, Inc.; AmerisourceBergen Corporation; CVS Health Corporation; Walgreens Boots Alliance, Inc.; Wal-Mart Stores, Inc.; Purdue Pharma L.P.; Purdue Pharma Inc.; The Purdue Frederick Company Inc.; Teva Pharmaceutical Industries, Ltd.;1 Teva Pharmaceuticals USA, Inc.; Cephalon, Inc.; Watson Laboratories, Inc.; Actavis LLC; Actavis Pharma, Inc., f/k/a Watson Pharma, Inc.; Johnson & Johnson; Janssen Pharmaceuticals, Inc.; Ortho-McNeil-Janssen Pharmaceuticals, Inc. n/k/a Janssen Pharmaceuticals, Inc.; Janssen Pharmaceutica Inc. n/k/a Janssen Pharmaceuticals, Inc.; Endo Health Solutions Inc.; Endo Pharmaceuticals Inc.; Allergan plc f/k/a Actavis plc; and Allergan Finance, LLC f/k/a Actavis, Inc. f/k/a Watson Laboratories, Inc., without waiver of any defenses, shall have through and including thirty (30) days after the later of (1) this Court's ruling on any motion to remand, should any party file one, or (2) the JPML's final decision regarding whether to transfer this case to the MDL, to move, answer, or otherwise respond to Plaintiffs' Complaint.
IT IS SO ORDERED.
